SCHEMBL1021601

SCHEMBL1021601

Cc1ccc(N)nc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL29112829 0.87 NOS2 (0.75)
SCHEMBL17551 0.78
SCHEMBL1653770 0.78
SCHEMBL31105996 0.78
Hydrochloric Acid SCHEMBL27833646 0.76 NOS2 (0.61)
SCHEMBL2828386 0.76
SCHEMBL1019361 0.74
SCHEMBL91461 0.74
SCHEMBL18712146 0.74
SCHEMBL558598 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110809577-A Modulators of adenosine A2A receptor 雷沃医疗有限公司 2020-02-18 CN claimed
US-9701691-B2 Thienopyrimidine compounds HOFFMAN-LA ROCHE INC. (US) 2017-07-11 US claimed
EP-2802590-B1 THIENOPYRIMIDINE COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-03-01 EP claimed
EP-2802590-A1 THIENOPYRIMIDINE COMPOUNDS F. Hoffmann-La Roche AG (CH) 2014-11-19 EP claimed
CN-101657480-B Alkali-developable resins, method for preparing the same and photosensitive composition comprising the alkali-developable resins LG CHEMICAL LTD 2013-09-04 CN claimed
WO-2013104575-A1 THIENOPYRIMIDINE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2013-07-18 WO claimed
US-20130178460-A1 THIENOPYRIMIDINE COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2013-07-11 US claimed
CN-102126951-A Crosslinkable compound and photosensitive composition comprising the same LG CHEMICAL LTD 2011-07-20 CN claimed
CN-101657480-A Alkali-developable resins, its preparation method and comprise the photosensitive composition of this alkali-developable resins LG CHEMICAL LTD KR 2010-02-24 CN claimed
US-12441724-B2 Inhibitors of plasma kallikrein and uses thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-10-14 US disclosed
EP-4615839-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE Bristol-Myers Squibb Company (US) 2025-09-17 EP disclosed
CN-120152973-A Protein tyrosine phosphatase inhibitors, compositions, and methods of use 百时美施贵宝公司 2025-06-13 CN disclosed
EP-3604305-B1 NOVEL PYRIDONE CARBOXYLIC ACID DERIVATIVE OR SALT THEREOF WAKUNAGA PHARMA CO LTD (JP) 2024-08-28 EP disclosed
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
CN-1194996-A Photocrosslinkable polymers ROLIC AG (CH) 1998-10-07 CN disclosed
WO-1996018616-A1 SUBSTITUTED 2-AMINOPYRIDINES AS INHIBITORS OF NITRIC OXIDE SYNTHASE MERCK & CO., INC. (US) 1996-06-20 WO disclosed
WO-1992007468-A1 HERBICIDES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-05-14 WO disclosed
WO-1991017979-A1 PROCESS FOR THE PREPARATION OF 2-N-ACYLAMINOPYRIDINES AND 2-AMINOPYRIDINES FROM 5-OXOALKANENITRILE OXIMES DSM N.V. (NL) 1991-11-28 WO disclosed
EP-0135833-B1 METHOD FOR THE PREPARATION OF 2-AMINO-ALKYLPYRIDINES BAYER AG (DE) 1987-10-28 EP disclosed
US-4628097-A Process for the preparation of 2-amino-alkylpyridines BAYER AKTIENGESELLSCHAFT (DE) 1986-12-09 US disclosed